fbpx Skip to main content

TUESDAY, March 2, 2021 (HealthDay News) — Birth weight modifies the association between adulthood levels of circulating insulin-like growth factor-1 (IGF-1) and development of type 2 diabetes (T2D), with an inverse association seen among those with a birth weight ≥2.5 kg, according to a study published online March 1 in BMJ Open Diabetes Research & Care.

Tingting Geng, from the National University of Singapore, and colleagues examined the interaction between circulating IGF-1 and birth weight in relation to T2D in a cohort of 181,090 adults, aged 39 to 70 years, in the U.K. Biobank Study. A chemiluminescent immunoassay method was used to determine serum IGF-1 levels.

During an average follow-up of 9.9 years, the researchers identified 3,299 incident T2D cases. IGF-1 levels were inversely associated with T2D risk in a dose-dependent manner among participants with a birth weight ≥2.5 kg. In contrast, no significant association was seen among those with a birth weight <2.5 kg. There was no interaction noted for the genetic risk score of birth weight with IGF-1 levels in relation to T2D risk.

“Our data indicate that the relation between adulthood IGF-1 and T2D is significantly modified by birth weight,” the authors write. “Our findings highlight the importance of early-life risk factors in the development of the lifecourse prevention strategies targeting on IGF-1 and T2D.”

Abstract/Full Text

You May Also Like::  Flavan-3-ol Intake Appears to Lower Systolic Blood Pressure

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More